Oct 24, 2024 09:20 AM
CX DAILY
CX Daily: Smash IPO Doesn’t Shake Investors’ AI Pharma Doubts
00:00/00:00
Listen to this article
1x
Subscribe now
Listen to the full version
Listen to the full version
pictureA visitor checks out a booth at the World Artificial Intelligence Conference in Shanghai on July 5. Photo: VCG
AI /
In Depth: Smash IPO doesn’t shake investors’ AI Pharma doubts
Drug researcher QuantumPharm Inc. recently made headlines for becoming the first-ever Chinese artificial intelligence (AI) pharma company to go public and the first firm to list under a new rule that aims to encourage more tech IPOs.
Many saw the listing, reportedly Hong Kong’s third-largest this year, as a welcome sign that investors were beginning to take an interest in AI pharma again after a prolonged funding drought.
Register to read this article for free.
Register
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
Share this article
Open WeChat and scan the QR code
- PODCAST
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新